Skip to main content
logo
Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Jul 24, 2026, 1:22 PM EST

Nymox Pharmaceutical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
095530110192
Market Cap Growth
-99.63%-82.82%86.49%-73.23%-42.54%24.63%
Enterprise Value
3105527108187
Last Close Price
0.000.100.590.321.302.48

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
-----38367.59
PB Ratio
0.00-1.39-17.34-61.22-217.8589.44
P/TBV Ratio
-----89.44

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
-----37312.99

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
-0.48-0.48-0.24-0.36-0.770.20
Net Debt / Equity Ratio
-0.47-0.47-0.212.550.87-1.48
Net Debt / EBITDA Ratio
-0.75-0.75-0.080.190.040.27
Net Debt / FCF Ratio
-1.24-1.24-0.170.240.050.32
Asset Turnover
-----0.00
Inventory Turnover
-----0.14
Quick Ratio
0.010.010.020.670.471.85
Current Ratio
0.090.090.160.690.581.98
Return on Equity (ROE)
-----1529.84%-419.74%
Return on Assets (ROA)
-417.94%-417.94%-463.48%-271.02%-270.13%-149.00%
Return on Capital Employed (ROCE)
63.20%63.20%263.20%1380.10%3645.50%-492.90%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-21382.33%-47.51%-16.07%-22.29%-11.37%-6.12%
FCF Yield
-12381.00%-27.51%-7.38%-17.64%-8.91%-5.24%
Buyback Yield / Dilution
-3.05%-2.16%-2.58%-9.04%-11.04%-7.23%